Chris DeRespino

Chris DeRespino has been in the business industry for over 18 years. Chris began their career in 2003 as a Senior Consultant at CSC Global Health Solutions Consulting. In 2007, they became a Summer Associate - Operations Planning and Analysis at Pfizer. A year later, they were promoted to Director - Business Development Evaluation & Strategy. In 2013, they moved to Onyx Pharmaceuticals as the Director - Asset Acquisition / Business Development. That same year, they also joined Amgen as the Executive Director - Business Development. In 2021, DeRespino became the Chief Business Officer at 3T Biosciences and the Chief Business Officer / Acting CFO at Adverum Biotechnologies, Inc.

Chris DeRespino has a Bachelor of Science in Engineering in Biomedical Engineering from The Johns Hopkins University and a Master of Business Administration in Quantitative Finance & Marketing from NYU Stern School of Business.